ProMab Biotechnologies: Caribou Biosciences and ProMab Biotechnologies Announce Sale and Assignment Agreement for Humanized scFv Targeting BCMA

Caribou Biosciences Inc. a leading CRISPR genome editing company and ProMab Biotechnologies Inc. a biotechnology CROCDMO specializing in antibody engineering and CART development today announced a sale and assignment agreement under which Caribou gains acc...